The International Collaborative Study of Maternal Phenylketonuria Status Report 1998

R. Koch, E. Friedman, C. Azen, W. Hanley, H. Levy, Reuben Matalon, B. Rouse, F. Trefz, S. Waisbren, K. Michals-Matalon, P. Acosta, F. Güttler, K. Ullrich, L. Platt, F. De La Cruz

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The Maternal PKU Study began in 1984 and during the intervening years, 572 pregnancies in women with hyperphenylalaninemia (HPA) and 99 controls and their outcomes have been evaluated. Among Women with HPA who delivered a live infant, only 15.9% were treated and in metabolic control preconceptionally; however, another 18.4% were in control by 10 weeks. Compared to the results reported by Lenke and Levy in 1980, there is a marked improvement in outcome with treatment. Microcephaly was unusual in preconceptionally treated pregnancies with well-controlled phenylalanine-restricted diets. Even in pregnancies that established control after conception but before the 8th week, congenital heart disease did not occur in the offspring; however, it did occur in 12% of pregnancies not achieving control until after 10 weeks of pregnancy. The recommended level of blood phenylalanine during pregnancy is 120-360 μmol/L. Best results were obtained by close cooperation between the attending obstetrician and a metabolic team experienced in the care of persons with phenylketonuria.

Original languageEnglish (US)
Pages (from-to)117-121
Number of pages5
JournalMental Retardation and Developmental Disabilities Research Reviews
Volume5
Issue number2
DOIs
StatePublished - 1999

Fingerprint

Maternal Phenylketonuria
Pregnancy
Phenylketonurias
Phenylalanine
Microcephaly
Heart Diseases
Diet

Keywords

  • Congenital heart disease
  • Maternal Phenylketonuria Collaborative Study
  • Phenylalanine
  • Phenylketonuria
  • Wechsler Adult Intelligence Quotient- Revised (WAIS-R)
  • Wechsler Intelligence Quotient-Revised (WISC-R)

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Neuropsychology and Physiological Psychology
  • Genetics(clinical)

Cite this

The International Collaborative Study of Maternal Phenylketonuria Status Report 1998. / Koch, R.; Friedman, E.; Azen, C.; Hanley, W.; Levy, H.; Matalon, Reuben; Rouse, B.; Trefz, F.; Waisbren, S.; Michals-Matalon, K.; Acosta, P.; Güttler, F.; Ullrich, K.; Platt, L.; De La Cruz, F.

In: Mental Retardation and Developmental Disabilities Research Reviews, Vol. 5, No. 2, 1999, p. 117-121.

Research output: Contribution to journalArticle

Koch, R, Friedman, E, Azen, C, Hanley, W, Levy, H, Matalon, R, Rouse, B, Trefz, F, Waisbren, S, Michals-Matalon, K, Acosta, P, Güttler, F, Ullrich, K, Platt, L & De La Cruz, F 1999, 'The International Collaborative Study of Maternal Phenylketonuria Status Report 1998', Mental Retardation and Developmental Disabilities Research Reviews, vol. 5, no. 2, pp. 117-121. https://doi.org/10.1002/(SICI)1098-2779(1999)5:2<117::AID-MRDD4>3.0.CO;2-W
Koch, R. ; Friedman, E. ; Azen, C. ; Hanley, W. ; Levy, H. ; Matalon, Reuben ; Rouse, B. ; Trefz, F. ; Waisbren, S. ; Michals-Matalon, K. ; Acosta, P. ; Güttler, F. ; Ullrich, K. ; Platt, L. ; De La Cruz, F. / The International Collaborative Study of Maternal Phenylketonuria Status Report 1998. In: Mental Retardation and Developmental Disabilities Research Reviews. 1999 ; Vol. 5, No. 2. pp. 117-121.
@article{9b9f7335a3ab4bf4a7844f20d0d3b832,
title = "The International Collaborative Study of Maternal Phenylketonuria Status Report 1998",
abstract = "The Maternal PKU Study began in 1984 and during the intervening years, 572 pregnancies in women with hyperphenylalaninemia (HPA) and 99 controls and their outcomes have been evaluated. Among Women with HPA who delivered a live infant, only 15.9{\%} were treated and in metabolic control preconceptionally; however, another 18.4{\%} were in control by 10 weeks. Compared to the results reported by Lenke and Levy in 1980, there is a marked improvement in outcome with treatment. Microcephaly was unusual in preconceptionally treated pregnancies with well-controlled phenylalanine-restricted diets. Even in pregnancies that established control after conception but before the 8th week, congenital heart disease did not occur in the offspring; however, it did occur in 12{\%} of pregnancies not achieving control until after 10 weeks of pregnancy. The recommended level of blood phenylalanine during pregnancy is 120-360 μmol/L. Best results were obtained by close cooperation between the attending obstetrician and a metabolic team experienced in the care of persons with phenylketonuria.",
keywords = "Congenital heart disease, Maternal Phenylketonuria Collaborative Study, Phenylalanine, Phenylketonuria, Wechsler Adult Intelligence Quotient- Revised (WAIS-R), Wechsler Intelligence Quotient-Revised (WISC-R)",
author = "R. Koch and E. Friedman and C. Azen and W. Hanley and H. Levy and Reuben Matalon and B. Rouse and F. Trefz and S. Waisbren and K. Michals-Matalon and P. Acosta and F. G{\"u}ttler and K. Ullrich and L. Platt and {De La Cruz}, F.",
year = "1999",
doi = "10.1002/(SICI)1098-2779(1999)5:2<117::AID-MRDD4>3.0.CO;2-W",
language = "English (US)",
volume = "5",
pages = "117--121",
journal = "Mental Retardation and Developmental Disabilities Research Reviews",
issn = "1080-4013",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - The International Collaborative Study of Maternal Phenylketonuria Status Report 1998

AU - Koch, R.

AU - Friedman, E.

AU - Azen, C.

AU - Hanley, W.

AU - Levy, H.

AU - Matalon, Reuben

AU - Rouse, B.

AU - Trefz, F.

AU - Waisbren, S.

AU - Michals-Matalon, K.

AU - Acosta, P.

AU - Güttler, F.

AU - Ullrich, K.

AU - Platt, L.

AU - De La Cruz, F.

PY - 1999

Y1 - 1999

N2 - The Maternal PKU Study began in 1984 and during the intervening years, 572 pregnancies in women with hyperphenylalaninemia (HPA) and 99 controls and their outcomes have been evaluated. Among Women with HPA who delivered a live infant, only 15.9% were treated and in metabolic control preconceptionally; however, another 18.4% were in control by 10 weeks. Compared to the results reported by Lenke and Levy in 1980, there is a marked improvement in outcome with treatment. Microcephaly was unusual in preconceptionally treated pregnancies with well-controlled phenylalanine-restricted diets. Even in pregnancies that established control after conception but before the 8th week, congenital heart disease did not occur in the offspring; however, it did occur in 12% of pregnancies not achieving control until after 10 weeks of pregnancy. The recommended level of blood phenylalanine during pregnancy is 120-360 μmol/L. Best results were obtained by close cooperation between the attending obstetrician and a metabolic team experienced in the care of persons with phenylketonuria.

AB - The Maternal PKU Study began in 1984 and during the intervening years, 572 pregnancies in women with hyperphenylalaninemia (HPA) and 99 controls and their outcomes have been evaluated. Among Women with HPA who delivered a live infant, only 15.9% were treated and in metabolic control preconceptionally; however, another 18.4% were in control by 10 weeks. Compared to the results reported by Lenke and Levy in 1980, there is a marked improvement in outcome with treatment. Microcephaly was unusual in preconceptionally treated pregnancies with well-controlled phenylalanine-restricted diets. Even in pregnancies that established control after conception but before the 8th week, congenital heart disease did not occur in the offspring; however, it did occur in 12% of pregnancies not achieving control until after 10 weeks of pregnancy. The recommended level of blood phenylalanine during pregnancy is 120-360 μmol/L. Best results were obtained by close cooperation between the attending obstetrician and a metabolic team experienced in the care of persons with phenylketonuria.

KW - Congenital heart disease

KW - Maternal Phenylketonuria Collaborative Study

KW - Phenylalanine

KW - Phenylketonuria

KW - Wechsler Adult Intelligence Quotient- Revised (WAIS-R)

KW - Wechsler Intelligence Quotient-Revised (WISC-R)

UR - http://www.scopus.com/inward/record.url?scp=0033010575&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033010575&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1098-2779(1999)5:2<117::AID-MRDD4>3.0.CO;2-W

DO - 10.1002/(SICI)1098-2779(1999)5:2<117::AID-MRDD4>3.0.CO;2-W

M3 - Article

AN - SCOPUS:0033010575

VL - 5

SP - 117

EP - 121

JO - Mental Retardation and Developmental Disabilities Research Reviews

JF - Mental Retardation and Developmental Disabilities Research Reviews

SN - 1080-4013

IS - 2

ER -